MPTP INDUCED PARKINSONISM
\ˌɛmpˌiːtˌiːpˈiː ɪndjˈuːst pɑːkˈɪnsənˌɪzəm], \ˌɛmpˌiːtˌiːpˈiː ɪndjˈuːst pɑːkˈɪnsənˌɪzəm], \ˌɛ_m_p_ˌiː_t_ˌiː_p_ˈiː_ ɪ_n_d_j_ˈuː_s_t p_ɑː_k_ˈɪ_n_s_ə_n_ˌɪ_z_ə_m]\
Sort: Oldest first
-
A condition caused by the neurotoxin 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. MPTP causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36 (2):250-8)
By DataStellar Co., Ltd
Word of the day
SQ10,643
- A serotonin antagonist with limited antihistaminic, anticholinergic, and immunosuppressive activity.